Which companies discussed China Exposure in Health Care in earnings calls?

515 companies mentioned china exposure across 1,471 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were Merck KGaA (21 calls), Revvity, Inc. (15 calls), Repligen Corporation (15 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning China Exposure
2024Q3135
2024Q4367
2025Q1457
2025Q2389
2025Q3412
2025Q4342
2026Q1419
2026Q2332
2026Q3176

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Merck KGaA MRK Health Care 21 Aug 6, 2026
Revvity, Inc. RVTY Health Care 15 Aug 4, 2026
Repligen Corporation RGEN Health Care 15 Jul 28, 2026
Bio-Techne Corporation TECH Health Care 15 May 12, 2026
Align Technology, Inc. ALGN Health Care 14 Jul 29, 2026
Charles River Laboratories International, Inc. CRL Health Care 13 Aug 5, 2026
Royalty Pharma plc RPRX Health Care 13 Aug 5, 2026
Qiagen N.V. QGEN Health Care 12 Aug 6, 2026
Summit Therapeutics Inc. SMMT Health Care 12 Jul 23, 2026
Cytokinetics, Incorporated CYTK Health Care 11 Aug 6, 2026
Pfizer Inc. PFE Health Care 11 Aug 4, 2026
GE HealthCare Technologies Inc. GEHC Health Care 11 Jul 29, 2026
Eli Lilly and Company LLY Health Care 10 Aug 5, 2026
Siemens Healthineers AG SHL Health Care 10 Jul 31, 2026
Novartis AG NOVN Health Care 10 Jul 21, 2026
Viatris Inc. VTRS Health Care 9 Aug 6, 2026
Nuvation Bio Inc. NUVB Health Care 9 Aug 6, 2026
Waters Corporation WAT Health Care 9 Aug 4, 2026
Daiichi Sankyo Company, Limited 4568 Health Care 9 Jul 31, 2026
GSK plc GSK Health Care 9 Jul 28, 2026
Thermo Fisher Scientific Inc. TMO Health Care 9 Jul 23, 2026
Agilent Technologies, Inc. A Health Care 9 Jun 3, 2026
Zai Lab Limited ZLAB Health Care 8 Aug 6, 2026
BeOne Medicines AG ONC Health Care 8 Aug 5, 2026
Bayer Aktiengesellschaft BAYN Health Care 8 Aug 4, 2026
Mettler-Toledo International Inc. MTD Health Care 8 Jul 31, 2026
Haleon plc HLN Health Care 8 Jul 30, 2026
Boston Scientific Corporation BSX Health Care 8 Jul 29, 2026
Bausch Health Companies Inc. BHC Health Care 8 Jul 29, 2026
Johnson & Johnson JNJ Health Care 8 Jul 15, 2026
Vertex Pharmaceuticals Incorporated VRTX Health Care 8 Jun 10, 2026
Becton, Dickinson and Company BDX Health Care 7 Aug 6, 2026
Zimmer Biomet Holdings, Inc. ZBH Health Care 7 Aug 5, 2026
Cytek Biosciences, Inc. CTKB Health Care 7 Aug 5, 2026
Bio-Rad Laboratories, Inc. BIO Health Care 7 Aug 4, 2026
Bruker Corporation BRKR Health Care 7 Aug 4, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 7 Jul 30, 2026
Merit Medical Systems, Inc. MMSI Health Care 7 Jul 30, 2026
Illumina, Inc. ILMN Health Care 7 Jul 30, 2026
Sanofi SAN Health Care 7 Jul 30, 2026
Bausch + Lomb Corporation BLCO Health Care 7 Jul 29, 2026
Roche Holding AG ROG Health Care 7 Jul 23, 2026
Danaher Corporation DHR Health Care 7 Jul 21, 2026
Lyell Immunopharma, Inc. LYEL Health Care 7 Jun 8, 2026
Astellas Pharma Inc. 4503 Health Care 7 Jun 3, 2026
Coloplast A/S COLOB Health Care 7 May 12, 2026
Telix Pharmaceuticals Limited TLX Health Care 7 Mar 17, 2026
LENZ Therapeutics, Inc. LENZ Health Care 6 Aug 11, 2026
Alcon Inc. ALC Health Care 6 Aug 11, 2026
Embecta Corp. EMBC Health Care 6 Aug 7, 2026

Representative quotes

Analysts): One last, if I may quickly. One last question, if I may. So given that we've been highlighting about the entire China Plus One multiple times in the previous quarters, we have been highlighting how we intend to take away volumes from China on specific products…
Supriya Lifescience Limited (SUPRIYA), August 14, 2026. Read the full transcript →
…bridging study? Is that what's going to be considered the registrational study by FDA? Or are they taking that clinical study in China into consideration as supportive evidence? Sean Brynjolfsson (Executives): Hi, Chase. I'll take that last question you have, and then Ipek can take…
Eton Pharmaceuticals, Inc. (ETON), August 13, 2026. Read the full transcript →
Internationally, I spent a significant amount of time during the quarter developing our opportunities across the Asia Pacific, particularly in Australia, New Zealand, China, and Hong Kong. We're seeing growing physician interest in SRT and believe there are attractive opportunities to build the business in these markets…
Sensus Healthcare, Inc. (SRTS), August 13, 2026. Read the full transcript →
…remove our exposure to setbacks with any one particular client. Deborah Honig (Attendees): Got it. And is there any update on orders into China? Has there been any progress... Cameron Groome (Executives): Yes, there has been. I mean, China was running at a $2 million, $3 million…
Microbix Biosystems Inc. (MBX), August 13, 2026. Read the full transcript →

Frequently asked questions

What is China Exposure and why are companies discussing it?

Demand, competition and geopolitical risk in China as management teams weigh exposure to the world's second-largest economy.

Which company mentioned china exposure most in Health Care in the past year?

Merck KGaA (MRK) led with 21 calls referencing china exposure, most recently on August 6, 2026.

How can I track china exposure mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related macro themes

Last updated: August 14, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (China, china, chinese market). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.